Pfizer MOU, Pharmaxis Advisory Cmte. Nod, Otsuka/BMS Withdraw Abilify Extension - Latest From PharmAsia News

Pfizer Signs MOU With Wuhan To Establish First R&D Center In Midwest China; Ranks Number One In China

11/25/09 11:11 GMT

Australia's Pharmaxis Breathing Easier Following U.S. FDA Advisory Committee Recommendation For Bronchial Test Aridol

11/25/09 10:12 GMT

Otsuka, Bristol-Myers Squibb Withdraw Abilify Extension Application In Europe

11/25/09 10:11 GMT

 

Not a subscriber to PharmAsia News? To register for a free trial, click here.